JNCE - Jounce Therapeutics Inc. (JNCE) CEO Rich Murray on Q1 2021 Results - Earnings Call Transcript
Jounce Therapeutics, Inc. (JNCE) Q1 2021 Earnings Conference Call May 04, 2021 08:00 AM ET Company Participants Malin Deon - Investor Relations Rich Murray - Chief Executive Officer & President Dmitri Wiederschain - Chief Scientific Officer Beth Trehu - Chief Medical Officer Kim Drapkin - Chief Financial Officer Conference Call Participants Ryan Deschner - Raymond James Swayampakula Ramakanth - H.C. Wainwright Colleen Kusy - Baird Boris Peaker - Cowen Nick Abbott - Wells Fargo Securities Zegbeh Jallah - ROTH Capital Ted Tenthoff - Piper Sandler Presentation Operator Good morning, ladies and gentlemen and welcome to the Jounce Therapeutics First Quarter 2021 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. As a reminder this conference call is being recorded at the company's request. I will now turn the call over to your
For further details see:
Jounce Therapeutics, Inc. (JNCE) CEO Rich Murray on Q1 2021 Results - Earnings Call Transcript